Melanoma researcher Pam Cassidy from Oregon Health & Sciences University discusses her fascination with the antioxidant selenocysteine, "the twenty-first amino acid," how her background in chemistry makes her concerned about the COVID variants, and the interface where research transitions from preclinical work to human trials.
